Dosage-rate in Radiotherapy

1944 ◽  
Vol 17 (203) ◽  
pp. 341-342
Author(s):  
Edith Paterson
Keyword(s):  
1988 ◽  
Vol 23 (8) ◽  
pp. 957-966 ◽  
Author(s):  
A. G. Jones ◽  
N. M. Teodossiev
Keyword(s):  

1935 ◽  
Vol 8 (92) ◽  
pp. 467-478 ◽  
Author(s):  
G. W. C. Kaye ◽  
G. E. Bell
Keyword(s):  
X Ray ◽  

1975 ◽  
Vol 9 (4) ◽  
pp. 381-382 ◽  
Author(s):  
M. Eliazian ◽  
A. Shahlapour ◽  
Y. Tamiji
Keyword(s):  

Injectable levamisole was used to control Paraspidodera uncinata in guinea-pigs of both sexes, pregnant and non-pregnant, and was found to be safe and efficient at a dosage rate of 25 mg/kg bodyweight.


1990 ◽  
Vol 25 (1) ◽  
pp. 158-169 ◽  
Author(s):  
D. J. Donahue ◽  
R. M. McPherson

The oviposition response of the twospotted spider mite (TSSM), Tetranychus urticae Koch, to direct treatment and residues of fenvalerate and permethrin on soybean was examined in the laboratory. Contact with pyrethroid residues (120 ppm) reduced eggs per mite-day for 72 h, then oviposition rates returned to normal. Most eggs (99%) on the control leaflets were oviposited directly on the leaf surface, while 83% and 78% of the eggs in the fenvalerate and permethrin treatments were suspended off the leaf surface onto trichomes, cage walls or in the silk webbing. Oviposition rate on untreated soybean foliage following five days on pyrethroid residues was essentially the same for all TSSM; however, the mites previously exposed to fenvalerate or permethrin residue still oviposited 85% and 37% of their eggs off the untreated leaf surface, respectively. A 120 ppm concentration of fenvalerate directly applied to TSSM resulted in 83% and 100% mortality after 24 h and 48 h and no oviposition. A similar direct exposure to permethrin (120 ppm) resulted in 54% mortality after 48 h, and a 58.5% reduction in eggs per mite-day. Direct exposure to a lower dosage rate (12 ppm) caused little mortality but significantly reduced the number of eggs produced in both fenvalerate and permethrin treatments for 48 h. Oviposition returned to normal after 72 h.


2013 ◽  
Vol 48 (9) ◽  
pp. 1019-1030 ◽  
Author(s):  
Susan Amrose ◽  
Ashok Gadgil ◽  
Venkat Srinivasan ◽  
Kristin Kowolik ◽  
Marc Muller ◽  
...  
Keyword(s):  

2002 ◽  
Vol 19 (2) ◽  
pp. 87-89 ◽  
Author(s):  
Edward B. Lack ◽  
John D. Rachel ◽  
Oana Patrascu

Introduction: Propofol-based anesthesia is a safe and effective method to provide intravenous sedation in office-based elective surgery. Clonidine is a drug that can provide anxiolytic sedation and hemodynamic stability, thus reducing the propofol consumption rate. This study reports the effect of 0.1 mg of clonidine administered orally and preoperatively on the dosage rate of propofol. The authors also describe the hemodynamic effects on patients undergoing elective liposculpture surgery. Materials and Methods: In a retrospective review, 20 American Society of Anesthesiologists grade I and grade II patients undergoing elective liposculpture surgery under monitored anesthesia care were studied. Ten patients received premedication (0.1 mg clonidine) 30–45 minutes before the induction of anesthesia. A control group receiving no premedication underwent the same procedures conducted by the same surgeon. Propofol dosage rate, heart rate, and blood pressure of both groups were monitored preoperatively, intraoperatively, and in the recovery room. Results: The average propofol dosage rate was 3.21 mg/ kg/h for the treatment group and 2.78 mg/kg/h for the control group. Hemodynamic stability was obtained for both groups during and after the treatment periods. Neither group had episodes of hypotension or changes in expectable recovery time. Discussion: Clonidine premedication of 0.1 mg orally did not reduce the requirements for propofol dosage rates. In contrast to previous studies using higher doses, this clonidine dose did not provide the beneficial effects of lowering the anesthetic requirement for propofol. However, hemodynamic stability was achieved, and no adverse effects were observed.


1983 ◽  
Vol 7 ◽  
pp. 139-139
Author(s):  
A. Whitelaw

The work of Dewey (1977), in Australia, showed that the oral administration of cupric oxide wire (CuON), in lengths of between 5-10 mm and a mean diameter of 0.5 mm, at a dosage rate of 10 g in a gelatin capsule to mature sheep, produced a steady increase in liver copper (Cu) concentrations over 16 days to levels over 1000 mg/kg DM above the initial levels. The 'needles' lodged primarily between the abomasal folds and, by 64 days, were no longer detectable. In grazing conditions, a dose of 20 g was administered to sheep. At neither dosage level were deleterious effects noted. Suttle (1981) administered 0.5 g CuON to hypocupraemic ewes maintained on a Cu-deficient diet and alleviated hypocupraemia for 111 days when the diet was supplemented with molybdenum (Mo) and sulphur (S), and 301 days when the diet was not so supplemented.


Sign in / Sign up

Export Citation Format

Share Document